Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Other Non-Current Liabilities (2017 - 2025)

Catheter Precision (VTAK) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $12.0 million as the latest value for Q2 2025.

  • Quarterly Other Non-Current Liabilities rose 40.62% to $12.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Jun 2025, up 40.62% year-over-year, with the annual reading at $7.0 million for FY2023, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q2 2025 was $12.0 million at Catheter Precision, up from $10.4 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $12.0 million in Q2 2025, with the low at $8848.0 in Q3 2023.
  • Average Other Non-Current Liabilities over 3 years is $6.9 million, with a median of $7.8 million recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities soared 110625.59% in 2024, then skyrocketed 40.62% in 2025.
  • Over 3 years, Other Non-Current Liabilities stood at $7.0 million in 2023, then surged by 40.48% to $9.8 million in 2024, then grew by 22.93% to $12.0 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $12.0 million, $10.4 million, and $9.8 million for Q2 2025, Q1 2025, and Q3 2024 respectively.